H
Helixmith Co Ltd
KOSDAQ:084990
Helixmith Co Ltd
KOSDAQ:084990
Price:
5 810
KRW
6.22%
Market Closed
Market Cap:
₩267.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Helixmith Co Ltd
KOSDAQ:084990
|
KR |
|
B
|
Berjaya Corporation Bhd
KLSE:BJCORP
|
MY |
|
G
|
Green Energy Group Ltd
HKEX:979
|
HK |
|
Reliance Global Holdings Ltd
HKEX:723
|
HK |
|
K
|
Keck Seng Investments Hong Kong Ltd
HKEX:184
|
HK |
Relative Value
The Relative Value of one Helixmith Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 810 KRW, Helixmith Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Helixmith Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Helixmith Co Ltd Competitors
Helixmith Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
H
|
Helixmith Co Ltd
KOSDAQ:084990
|
267.5B KRW | 71.5 | -50.7 | -28.3 | -20.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 6 | 87.1 | 14.5 | 20.1 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.7 | 29.4 | 22.2 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
